Proprietary Real-World Data
Enhance drug development with insights from robust, unique fit-for-purpose data
The use of real-world insights to inform decisions in drug and technology development is expanding as stakeholders continue to appreciate the value of evidence beyond clinical trial data. From early insights that aid trial design to post-marketing studies that assess a product’s value, safety and effectiveness in real-world use, real-world data (RWD) play a significant role.
Choosing the right RWD for your needs is imperative, but it can also be daunting. The accessibility and diversity of real-world data sources have expanded significantly in recent years, increasing the complexity of identifying the optimal data for your needs. Whatever answers you seek, the PPD™ clinical research business of Thermo Fisher Scientific can simplify your journey. Our solutions give you an efficient view into real-world patient health dynamics with a combination of:
- An expanding array of proprietary and specialized RWD sources
- Vast experience with hundreds of external data sources around the world
- Strategic data partnerships
- Innovative data collection strategies
- Comprehensive, advanced data analytics
Optimize your path to success with faster startup times for studies, tailored insights to advance your product more efficiently, and effective monitoring of safety, effectiveness and value in the real world. You can be confident that our specialized data solutions can unlock the promise of RWD — from any source, for any purpose.
Explore our proprietary RWD solutions
Real-world data solutions to accelerate your product at every phase
Not all data are created equal. We have prioritized investments in proprietary data sets, data partnerships and data technologies to ensure our clients receive access to the highest quality RWD.
Obtain robust, regulatory-grade data to inform your drug development plan, from pre-clinical and clinical development phases through commercialization and beyond, with our suite of proprietary clinical and patient-powered solutions.
Disease registries
Regulatory-grade, research-ready proprietary datasets and patient research have the power to unlock answers to specific questions, eliminating the lengthy data identification and contracting process. Our independent disease registries allow you to leverage our robust proprietary RWD for a complete view of real-world clinical practice, patient outcomes, safety and comparative effectiveness. Gain granular clinical effectiveness and robust drug safety insight with RWD collected across multiple disease registries. Backed by vigorous scientific rigor and expertise, these registries represent the gold standard for completeness in variables, including clinical trial endpoints not captured by other RWD sources.
Specialty electronic health records data
Electronic health records (EHRs) provide routinely collected data that are extremely useful in the study and advancement of drugs, devices and other medical interventions. Our PPD™ Vestrum Health™ real-world data provides real-time market trends alongside patient characteristics and outcomes occurring in retinal patients. Design studies that can assess demographic, clinical and anatomic profiles of patients seen in the real world through our unique and proprietary retina dataset.
Precision medicine and biospecimens
Medical treatments are no longer purely based on the “average” person, but rather often focus on a more personalized, precise intervention. This new direction holds excitement and hope for patients, especially those who are not obtaining relief from existing products for rare diseases, oncology indications and other health conditions.
Achieve your precision medicine goals with our existing library of clinically annotated biospecimens from our independent autoimmune disease registries or through customized collection. Using a comprehensive and rigorous biospecimen collection process, we ensure you have the right analysis of the right samples, including DNA, RNA, serum and plasma, to provide the level of detail you need to advance your research in the molecular understanding of disease and the development of novel therapeutics, diagnostics and prognostic tools.
Global real-world data expertise for powerful intelligence
As the volume of clinical data grows exponentially, it’s critical to engage with a data partner that has a deep understanding of and experience with extraction of valuable insight from a multitude of sources. Our data capabilities combine the best RWD sources and datasets with a supremely engaged and experienced team, delivering intelligence that stratifies the requirements of regulators, payors and health care professionals. Backed by a rich experience and understanding of primary data collection and existing secondary data sources, we recommend the optimal combination of standard and novel data sources to address your most critical research questions.
Connecting data from multiple data sources allows you to obtain more comprehensive information, including a clearer picture of a patient’s journey. The use of tokenization to help link datasets, such as our registry data with external sources, expands the breadth and depth of the analyses that provide valuable real-world evidence.
Partner with our data experts for clinical insights that answer critical research questions and improve patient care and outcomes.
Go from data to decision-making
RWD can be messy, incomplete, heterogeneous, and subject to various types of measurement errors and biases. That’s why we don’t just collect and curate data. We analyze, interpret and consult with you to provide multiple perspectives that inform discussions. Through a rigorous data analysis process, our integrated team of data scientists critically assesses available databases, evaluates vast datasets, uncovers gaps and anomalies, and deploys advanced statistical and analytical methodology to unearth hidden patterns and extract actionable insights to support your decision-making.